4.7 Article

S694 Comparative Efficacy and Safety of Ozanimod vs Adalimumab and Vedolizumab in Patients with Moderately to Severely Active Ulcerative Colitis

Journal

AMERICAN JOURNAL OF GASTROENTEROLOGY
Volume 116, Issue 1, Pages S314-S314

Publisher

Ovid Technologies (Wolters Kluwer Health)
DOI: 10.14309/01.ajg.0000776308.71765.85

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available